Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease
PharmacoEconomics, 08/19/09
Yu AP et al. – This analysis suggests that adalimumab maintenance therapy is a dominant strategy versus infliximab maintenance therapy for patients with moderate to severe Crohn's disease. Adalimumab appeared more effective and less costly than infliximab.
Related Articles
Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/30/09
Relevance Score: 69%
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease
Inflammatory Bowel Disease, 12/16/09
Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis
Gastrointestinal Endoscopy, 12/16/09
Genome wide association (GWA) predictors of anti-TNF[alpha] therapeutic responsiveness in pediatric inflammatory bowel disease
Inflammatory Bowel Disease, 12/16/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis
World Journal of Gastroenterology, 12/16/09
Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium After Simultaneous Pancreas-Kidney Transplantation
Transplantation Proceedings, 12/16/09
Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
Digestive Diseases and Sciences, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


